Entree Capital is a venture capital firm.
It has taken part in 8 funding rounds across 8 Israeli companies, leading 31,2,3.
Most recent: Undecimal Bio’s Seed of $18M1, announced Oct 13, 2026.
Israeli rounds
| Oct 13, 2026 | Undecimal Biobiotech, RNA therapeutics | Seed | $18M | Participant |
| Sep 22, 2026 | Chamelioai, legal tech | Series A | $26M | Lead |
| Sep 2, 2026 | CatchAI, productivity | Seed | $5M | Lead |
| Jul 16, 2026 | Horizon Tradefintech, ai | Pre-seed | $2M | Lead |
| Jul 8, 2026 | Altaai, martech | Series A | $25M | Participant |
| Jul 2, 2026 | Traysardefense, robotics | Seed | $25M | Participant |
| Jun 8, 2026 | PointFivedata, ai | Series B | $60M | Participant |
| Feb 25, 2026 | Guiddeai, devtools | Series B | $50M | Participant |
Israeli portfolio
Who invests alongside Entree Capital?
Sources
- 1CTech by Calcalist, Oct 13, 2026. “Undecimal Bio raises $18 million Seed to tackle a key obstacle in RNA medicines”
- 2Calcalist (CTech), Sep 22, 2026. “Chamelio raises $26 million Series A to replace legacy legal software with AI agents”
- 3Calcalist (CTech), Sep 2, 2026. “Catch raises $5 million Seed to put AI agents to work on executive drudgery”
Which Israeli startups has Entree Capital invested in?
Entree Capital has invested in Undecimal Bio, Chamelio, Catch, Horizon Trade, Alta, Traysar, PointFive and Guidde.
How many rounds has Entree Capital led?
Entree Capital led 3 rounds of the 8 rounds it joined.
What was Entree Capital’s most recent Israeli investment?
Undecimal Bio’s Seed of $18M, announced Oct 13, 2026.